| ||||||||||||||
|
|
|||||||||||||


*Department of Anesthesiology and
Office for Medical Research Administration, National Taiwan University Hospital, and
Department of Physiology, College of Medicine, National Taiwan University, Taipei, Taiwan
Address correspondence and reprint request to Chau-Fong Chen, PhD, Department of Physiology, College of Medicine, National Taiwan University, No. 7, Chung-Shan South Road, Taipei, Taiwan 10016, Republic of China. Address e-mail to chfochen{at}ha.mc ntu.edu.tw.
The release of a tourniquet produces reactive oxygen species (ROS), which can cause ischemia-reperfusion injury. We investigated the effects on ROS production in 22 adult ASA physical status III patients sedated with small-dose propofol infusion and IV midazolam undergoing elective total knee replacement under intrathecal anesthesia, allocated randomly to one of two groups. In the Propofol group, sedation was performed with propofol 0.2 mg/kg followed by infusion at a rate of 2 mg · kg-1 · h-1. In the Control group, IV midazolam 5 mg was given. ROS production was measured by lucigenin chemiluminescence analysis. Blood samples were obtained from the radial artery after spinal anesthesia, 1 min before release of the tourniquet and 5 and 20 min after reperfusion. The ischemic time was approximately 70 min. ROS production decreased nonsignificantly before reperfusion in both groups but increased significantly 5 and 20 min after reperfusion in the Midazolam group. In the Propofol group, no significant increase of ROS production was found. We conclude that small-dose propofol infusion attenuates ROS production in tourniquet-induced ischemia-reperfusion injury.
IMPLICATIONS: Small-dose propofol sedation, compared with IV midazolam, attenuates free radical production after release of the tourniquet during total knee replacement under spinal anesthesia.
This article has been cited by other articles:
![]() |
M. Carles, J. Dellamonica, J. Roux, D. Lena, J. Levraut, J. F. Pittet, P. Boileau, and M. Raucoules-Aime Sevoflurane but not propofol increases interstitial glycolysis metabolites availability during tourniquet-induced ischaemia reperfusion Br. J. Anaesth., January 1, 2008; 100(1): 29 - 35. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Kaplan, H. Yagmurdur, K. Kilinc, B. Baltaci, and S. Tezel The Protective Effects of Intravenous Anesthetics and Verapamil in Gut Ischemia/Reperfusion-Induced Liver Injury Anesth. Analg., November 1, 2007; 105(5): 1371 - 1378. [Abstract] [Full Text] [PDF] |
||||
![]() |
K.-X. Liu, T. Rinne, W. He, F. Wang, and Z. Xia Propofol attenuates intestinal mucosa injury induced by intestinal ischemia-reperfusion in the rat: [Le propofol attenue les lesions de la muqueuse intestinale provoquees par l'ischemie-reperfusion intestinale chez le rat] Can J Anesth, May 1, 2007; 54(5): 366 - 374. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Rodriguez-Lopez, P. Sanchez-Conde, F. S. Lozano, J. L. Nicolas, F. J. Garcia-Criado, C. Cascajo, and C. Muriel Laboratory investigation: Effects of propofol on the systemic inflammatory response during aortic surgery: [Essai en laboratoire : les effets du propofol sur la reaction inflammatoire generalisee pendant une operation de l'aorte]. Can J Anesth, July 1, 2006; 53(7): 701 - 710. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. G. Kevin, E. Novalija, and D. F. Stowe Reactive Oxygen Species as Mediators of Cardiac Injury and Protection: The Relevance to Anesthesia Practice Anesth. Analg., November 1, 2005; 101(5): 1275 - 1287. [Abstract] [Full Text] [PDF] |
||||
|